144 related articles for article (PubMed ID: 10426799)
1. K-ras oncogene mutation as a prognostic marker in non-small cell lung cancer: a combined analysis of 881 cases.
Huncharek M; Muscat J; Geschwind JF
Carcinogenesis; 1999 Aug; 20(8):1507-10. PubMed ID: 10426799
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of K-RAS mutations in patients with non-small cell lung cancer: a systematic review with meta-analysis.
Meng D; Yuan M; Li X; Chen L; Yang J; Zhao X; Ma W; Xin J
Lung Cancer; 2013 Jul; 81(1):1-10. PubMed ID: 23608713
[TBL] [Abstract][Full Text] [Related]
3. Implications and prognostic value of K-ras mutation for early-stage lung cancer in women.
Nelson HH; Christiani DC; Mark EJ; Wiencke JK; Wain JC; Kelsey KT
J Natl Cancer Inst; 1999 Dec; 91(23):2032-8. PubMed ID: 10580029
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of p53 mutations in non-small cell lung cancer: a meta-analysis of 829 cases from eight published studies.
Huncharek M; Kupelnick B; Geschwind JF; Caubet JF
Cancer Lett; 2000 May; 153(1-2):219-26. PubMed ID: 10779652
[TBL] [Abstract][Full Text] [Related]
5. Lack of prognostic significance of p53 and K-ras mutations in primary resected non-small-cell lung cancer on E4592: a Laboratory Ancillary Study on an Eastern Cooperative Oncology Group Prospective Randomized Trial of Postoperative Adjuvant Therapy.
Schiller JH; Adak S; Feins RH; Keller SM; Fry WA; Livingston RB; Hammond ME; Wolf B; Sabatini L; Jett J; Kohman L; Johnson DH
J Clin Oncol; 2001 Jan; 19(2):448-57. PubMed ID: 11208838
[TBL] [Abstract][Full Text] [Related]
6. Mutational activation of the K-ras oncogene and the effect of chemotherapy in advanced adenocarcinoma of the lung: a prospective study.
Rodenhuis S; Boerrigter L; Top B; Slebos RJ; Mooi WJ; van't Veer L; van Zandwijk N
J Clin Oncol; 1997 Jan; 15(1):285-91. PubMed ID: 8996154
[TBL] [Abstract][Full Text] [Related]
7. Assessment of somatic k-RAS mutations as a mechanism associated with resistance to EGFR-targeted agents: a systematic review and meta-analysis of studies in advanced non-small-cell lung cancer and metastatic colorectal cancer.
Linardou H; Dahabreh IJ; Kanaloupiti D; Siannis F; Bafaloukos D; Kosmidis P; Papadimitriou CA; Murray S
Lancet Oncol; 2008 Oct; 9(10):962-72. PubMed ID: 18804418
[TBL] [Abstract][Full Text] [Related]
8. K-ras mutations in non-small-cell lung carcinoma: a review.
Aviel-Ronen S; Blackhall FH; Shepherd FA; Tsao MS
Clin Lung Cancer; 2006 Jul; 8(1):30-8. PubMed ID: 16870043
[TBL] [Abstract][Full Text] [Related]
9. Detection of activated K-ras in non-small cell lung cancer by membrane array: a comparison with direct sequencing.
Chong IW; Chang MY; Sheu CC; Wang CY; Hwang JJ; Huang MS; Lin SR
Oncol Rep; 2007 Jul; 18(1):17-24. PubMed ID: 17549340
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of K-ras codon 12 mutations in patients with resected stage I and II non-small-cell lung cancer.
Graziano SL; Gamble GP; Newman NB; Abbott LZ; Rooney M; Mookherjee S; Lamb ML; Kohman LJ; Poiesz BJ
J Clin Oncol; 1999 Feb; 17(2):668-75. PubMed ID: 10080613
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of K-ras mutations, ras oncoprotein, and c-erb B-2 oncoprotein expression in adenocarcinoma of the lung.
Nemunaitis J; Klemow S; Tong A; Courtney A; Johnston W; Mack M; Taylor W; Solano M; Stone M; Mallams J; Mues G
Am J Clin Oncol; 1998 Apr; 21(2):155-60. PubMed ID: 9537203
[TBL] [Abstract][Full Text] [Related]
12. Mutational analysis of EGFR and K-RAS genes in lung adenocarcinomas.
Soung YH; Lee JW; Kim SY; Seo SH; Park WS; Nam SW; Song SY; Han JH; Park CK; Lee JY; Yoo NJ; Lee SH
Virchows Arch; 2005 May; 446(5):483-8. PubMed ID: 15815931
[TBL] [Abstract][Full Text] [Related]
13. Correlation between K-ras gene mutation and prognosis of patients with nonsmall cell lung carcinoma.
Cho JY; Kim JH; Lee YH; Chung KY; Kim SK; Gong SJ; You NC; Chung HC; Roh JK; Kim BS
Cancer; 1997 Feb; 79(3):462-7. PubMed ID: 9028355
[TBL] [Abstract][Full Text] [Related]
14. Noninvasive image texture analysis differentiates K-ras mutation from pan-wildtype NSCLC and is prognostic.
Weiss GJ; Ganeshan B; Miles KA; Campbell DH; Cheung PY; Frank S; Korn RL
PLoS One; 2014; 9(7):e100244. PubMed ID: 24987838
[TBL] [Abstract][Full Text] [Related]
15. K-ras and p53 mutations are an independent unfavourable prognostic indicator in patients with non-small-cell lung cancer.
Fukuyama Y; Mitsudomi T; Sugio K; Ishida T; Akazawa K; Sugimachi K
Br J Cancer; 1997; 75(8):1125-30. PubMed ID: 9099959
[TBL] [Abstract][Full Text] [Related]
16. Skp2 gene copy number aberrations are common in non-small cell lung carcinoma, and its overexpression in tumors with ras mutation is a poor prognostic marker.
Zhu CQ; Blackhall FH; Pintilie M; Iyengar P; Liu N; Ho J; Chomiak T; Lau D; Winton T; Shepherd FA; Tsao MS
Clin Cancer Res; 2004 Mar; 10(6):1984-91. PubMed ID: 15041716
[TBL] [Abstract][Full Text] [Related]
17. Multiple molecular marker testing (p53, C-Ki-ras, c-erbB-2) improves estimation of prognosis in potentially curative resected non-small cell lung cancer.
Schneider PM; Praeuer HW; Stoeltzing O; Boehm J; Manning J; Metzger R; Fink U; Wegerer S; Hoelscher AH; Roth JA
Br J Cancer; 2000 Aug; 83(4):473-9. PubMed ID: 10945494
[TBL] [Abstract][Full Text] [Related]
18. [K-ras mutation predictive significance in platinum based chemotherapeutic protocols in patients with advanced non-small cell lung cancer].
Cvetković G; Plavec G; Tomić I; Ilić V; Magić Z; Tatomirović Z; Novković D; Milić R; Karlicić V
Vojnosanit Pregl; 2009 Feb; 66(2):149-55. PubMed ID: 19281127
[TBL] [Abstract][Full Text] [Related]
19. K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung.
Slebos RJ; Kibbelaar RE; Dalesio O; Kooistra A; Stam J; Meijer CJ; Wagenaar SS; Vanderschueren RG; van Zandwijk N; Mooi WJ
N Engl J Med; 1990 Aug; 323(9):561-5. PubMed ID: 2199829
[TBL] [Abstract][Full Text] [Related]
20. Is K-ras gene mutation a prognostic factor for colorectal cancer: a systematic review and meta-analysis.
Ren J; Li G; Ge J; Li X; Zhao Y
Dis Colon Rectum; 2012 Aug; 55(8):913-23. PubMed ID: 22810479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
